Abstract:Craniofacial bone loss is a complex clinical problem with limited regenerative solutions. Currently, BMP2 is used as a bone-regenerative therapy in adults, but in pediatric cases of bone loss, it is not FDA-approved due to concerns of life-threatening inflammation and cancer. Development of a bone-regenerative therapy for children will transform our ability to reduce the morbidity associated with current autologous bone grafting techniques. We discovered that JAGGED1 (JAG1) induces cranial neural crest (CNC) cell osteoblast commitment during craniofacial intramembranous ossification, suggesting that exogenous JAG1 delivery is a potential craniofacial bone-regenerative approach. In this study, we found that JAG1 delivery using synthetic hydrogels containing O9-1 cells, a CNC cell line, into critical-sized calvarial defects in C57BL/6 mice provided robust bone-regeneration. Since JAG1 signals through canonical (Hes1/Hey1) and non-canonical (JAK2) NOTCH pathways in CNC cells, we used RNAseq to analyze transcriptional pathways activated in CNC cells treated with JAG1±DAPT, a NOTCH-canonical pathway inhibitor. JAG1 upregulated expression of multiple NOTCH canonical pathway genes (Hes1), which were downregulated in the presence of DAPT. JAG1 also induced bone chemokines (Cxcl1), regulators of cytoskeletal organization and cell migration (Rhou), signaling targets (STAT5), promoters of early osteoblast cell proliferation (Prl2c2, Smurf1 and Esrra), and, inhibitors of osteoclasts (Id1). In the presence of DAPT, expression levels of Hes1 and Cxcl1 were decreased, whereas, Prl2c2, Smurf1, Esrra, Rhou and Id1 remain elevated, suggesting that JAG1 induces osteoblast proliferation through these non-canonical genes. Pathway analysis of JAG1+DAPT-treated CNC cells revealed significant upregulation of multiple non-canonical pathways, including the cell cycle, tubulin pathway, regulators of Runx2 initiation and phosphorylation of STAT5 pathway. In total, our data show that JAG1 upregulates multiple pathways involved in osteogenesis, independent of the NOTCH canonical pathway. Moreover, our findings suggest that JAG1 delivery using a synthetic hydrogel, is a bone-regenerative approach with powerful translational potential.

PLGA-based Control Release of Noggin Blocks the Premature Fusion of Cranial Sutures Caused by Retinoic Acid

Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.

Noggin-Loaded PLA/PCL Patch Inhibits BMP-Initiated Reactive Astrogliosis

PIN1 is a new therapeutic target of craniosynostosis

Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus

Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis

Retinoic Acid Regulates Bone Morphogenic Protein Signal Duration By Promoting The Degradation Of Phosphorylated Smad1

Rapidly polymerizing injectable click hydrogel therapy to delay bone growth in a murine re-synostosis model.

Embryonic inhibition of colony-stimulating factor 1 receptor induces enlarged cartilaginous zone of the midpalatal suture in postnatal mice

Role of Notch Signaling in the Physiological Patterning of Posterofrontal and Sagittal Cranial Sutures

Molecular Mechanisms For Short Root Anomaly

Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis

Skeletal stem and progenitor cells maintain cranial suture patency and prevent craniosynostosis

Smad7 Modulates Tgf Beta Signaling During Cranial Suture Development To Maintain Suture Patency

Enhanced BMP Signalling Causes Growth Plate Cartilage Dysrepair in Rats

Stimulation of Bone Formation in the Expanding Premaxillary Suture with a GSK-3β Inhibitor.

RNA Interference and Inhibition of MEK-ERK Signaling Prevent Abnormal Skeletal Phenotypes in a Mouse Model of Craniosynostosis.

<i>Gnas</i> Loss Causes Chondrocyte Fate Conversion in Cranial Suture Formation

Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model

JAGGED1 stimulates cranial neural crest cell osteoblast commitment pathways and bone regeneration independent of canonical NOTCH signaling

Periostin/Bone Morphogenetic Protein 1 axis axis regulates proliferation and osteogenic differentiation of sutured mesenchymal stem cells and affects coronal suture closure in the TWIST1+/− mouse model of craniosynostosis